Total Payments
$151,669
2024 Payments
$6,643
Companies
10
Transactions
203
Medicare Patients
1,538
Medicare Billing
$326,249
Payment Breakdown by Category
Other$114,775 (75.7%)
Consulting$20,240 (13.3%)
Travel$13,460 (8.9%)
Food & Beverage$3,042 (2.0%)
Education$152.65 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $114,775 | 63 | 75.7% |
| Consulting Fee | $20,240 | 8 | 13.3% |
| Travel and Lodging | $13,460 | 79 | 8.9% |
| Food and Beverage | $3,042 | 49 | 2.0% |
| Education | $152.65 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aurinia Pharma U.S., Inc. | $128,249 | 168 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $9,868 | 9 | $0 (2021) |
| GlaxoSmithKline, LLC. | $5,970 | 4 | $0 (2023) |
| Rockwell Medical, Inc. | $2,800 | 1 | $0 (2020) |
| BAXTER HEALTHCARE | $1,513 | 13 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $1,502 | 3 | $0 (2019) |
| Keryx Biopharmaceuticals, Inc. | $1,500 | 1 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $130.76 | 2 | $0 (2022) |
| Mallinckrodt Enterprises LLC | $74.99 | 1 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $61.20 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,643 | 7 | Aurinia Pharma U.S., Inc. ($6,643) |
| 2023 | $18,675 | 15 | Aurinia Pharma U.S., Inc. ($16,725) |
| 2022 | $51,620 | 87 | Aurinia Pharma U.S., Inc. ($47,469) |
| 2021 | $59,771 | 66 | Aurinia Pharma U.S., Inc. ($57,411) |
| 2020 | $2,800 | 1 | Rockwell Medical, Inc. ($2,800) |
| 2019 | $10,660 | 26 | AKEBIA THERAPEUTICS INC ($7,508) |
| 2018 | $1,500 | 1 | Keryx Biopharmaceuticals, Inc. ($1,500) |
All Payment Transactions
203 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/29/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $74.19 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/29/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $70.98 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/15/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/11/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Travel and Lodging | In-kind items and services | $160.88 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/10/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $97.21 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/23/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Travel and Lodging | In-kind items and services | $539.34 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/13/2023 | Aurinia Pharma U.S., Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| 11/29/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Education | In-kind items and services | $8.23 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/16/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Education | In-kind items and services | $8.23 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/10/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 07/24/2023 | Aurinia Pharma U.S., Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| 06/15/2023 | Aurinia Pharma U.S., Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| 05/30/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/15/2023 | Aurinia Pharma U.S., Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| 04/24/2023 | Aurinia Pharma U.S., Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| 04/03/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/30/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/30/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/28/2023 | Aurinia Pharma U.S., Inc. | — | Travel and Lodging | In-kind items and services | $508.95 | General |
| 03/02/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 01/03/2023 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| 12/15/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $750.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/16/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $2,000.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/16/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 362 | 813 | $393,868 | $74,073 |
| 2022 | 10 | 385 | 876 | $427,204 | $77,619 |
| 2021 | 9 | 335 | 767 | $391,834 | $74,934 |
| 2020 | 11 | 456 | 1,070 | $552,342 | $99,623 |
Total Patients
1,538
Total Services
3,526
Medicare Billing
$326,249
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 13 | 90 | $92,160 | $22,881 | 24.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 89 | 221 | $54,587 | $14,759 | 27.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 67 | 185 | $146,150 | $11,321 | 7.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 54 | 69 | $34,362 | $7,494 | 21.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 43 | 67 | $17,554 | $5,058 | 28.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 49 | 116 | $20,300 | $4,870 | 24.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 40 | $13,480 | $4,103 | 30.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 25 | $15,275 | $3,588 | 23.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 15 | 76 | $77,824 | $19,172 | 24.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 90 | 276 | $68,172 | $16,970 | 24.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 74 | 212 | $167,480 | $13,330 | 8.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 53 | 60 | $29,880 | $6,865 | 23.0% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 14 | 29 | $21,547 | $5,030 | 23.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 41 | 60 | $15,720 | $4,720 | 30.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 26 | 26 | $15,886 | $4,458 | 28.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 41 | $13,817 | $3,551 | 25.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 36 | 83 | $14,525 | $2,767 | 19.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 13 | 13 | $2,353 | $754.74 | 32.1% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 16 | 84 | $86,016 | $22,205 | 25.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 88 | 260 | $64,220 | $16,354 | 25.5% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 68 | 176 | $139,040 | $11,125 | 8.0% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 16 | 40 | $29,720 | $7,282 | 24.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 52 | 62 | $30,876 | $6,963 | 22.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 21 | 21 | $12,831 | $3,681 | 28.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 29 | 37 | $9,694 | $2,962 | 30.6% |
About Dr. Joshua Kaplan, M.D
Dr. Joshua Kaplan, M.D is a Nephrology healthcare provider based in Newark, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407881287.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Kaplan, M.D has received a total of $151,669 in payments from pharmaceutical and medical device companies, with $6,643 received in 2024. These payments were reported across 203 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($114,775).
As a Medicare-enrolled provider, Kaplan has provided services to 1,538 Medicare beneficiaries, totaling 3,526 services with total Medicare billing of $326,249. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Newark, NJ
- Active Since 07/11/2006
- Last Updated 02/03/2022
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1407881287
Products in Payments
- LUPKYNIS (Drug) $97,346
- TRIFERIC (Drug) $2,800
- ORENCIA (Biological) $1,502
- Auryxia (Drug) $1,500
- Non-Franchise (NOF) - NonProduct (Biological) $1,291
- Renal - Non Product Related (Biological) $222.01
- Kerendia (Drug) $130.76
- ACTHAR (Biological) $74.99
- SAMSCA (Drug) $61.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Newark
Dr. William Dahms, D.o, D.O
Nephrology — Payments: $142,020
Nephrology $142,020
Prayus Tailor, M.d, M.D
Nephrology — Payments: $132,452
Nephrology $132,452
Theodore Saad, M.d, M.D
Nephrology — Payments: $33,222
Nephrology $33,222
Manthodi Faisal, Md, MD
Nephrology — Payments: $5,716
Nephrology $5,716
Dr. Piyaporn Apivatanagul, Md, MD
Nephrology — Payments: $4,693
Nephrology $4,693
Lindsey Slater, M.d, M.D
Nephrology — Payments: $3,482
Nephrology $3,482